CTI Clinical Trial and Consulting Services Opens Sao Paulo, Brazil Office
CTI Clinical Trial and Consulting Services announces that it has opened an office in S?o Paulo, Brazil
CTI Clinical Trial and Consulting Services (CTI), an international, privately held, full-service contract research organization announces that it has opened an office in São Paulo, Brazil. The office is opened through the wholly-owned subsidiary, CTI Clinical Brasil Serviços de Pesquisas Clínicas LTDA.
“We have been working on behalf of our pharmaceutical and biotechnology clients in the Latin America region for a number of years, and we believe that the region is one of the most important and fastest growing,” according to Patrick Earley, Vice President, International. “São Paulo, the largest city in Brazil and the largest city in the southern hemisphere, is key for our global expansion. Latin America’s immense population allows for a vast pool of potential trial patients and access to some of the top medical centers and universities in the world.”
With offices in North America, Europe, and South America, CTI has been working for over fifteen years in the drug development industry, specializing in clinical research programs involving critically ill patient populations.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
